These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 12945916

  • 1. Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma.
    Chen YK, Liu FY, Yen RF, Kao CH.
    Acad Radiol; 2003 Aug; 10(8):835-9. PubMed ID: 12945916
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Technetium-99m tetrofosmin single photon emission computed tomography to detect metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Wu HS, Liu FY, Huang WS, Liu YC, Chang CT, Kao CH.
    Clin Radiol; 2003 Oct; 58(10):787-90. PubMed ID: 14521888
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.
    Kao CH, Tsai SC, Wang JJ, Ho YJ, Yen RF, Ho ST.
    Cancer; 2001 Jul 15; 92(2):434-9. PubMed ID: 11466699
    [Abstract] [Full Text] [Related]

  • 6. F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Hung MC, Wu HS, Kao CH, Chen WK, Changlai SP.
    Endocr Res; 2003 May 15; 29(2):169-75. PubMed ID: 12856803
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tc-99m MIBI SPECT in detecting metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Hsu CH, Liu FY, Yen RF, Kao CH.
    Endocr Res; 2003 Feb 15; 29(1):9-15. PubMed ID: 12665314
    [Abstract] [Full Text] [Related]

  • 10. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P, Kohlfürst S.
    Semin Nucl Med; 2006 Jul 15; 36(3):194-205. PubMed ID: 16762610
    [Abstract] [Full Text] [Related]

  • 11. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.
    Giorgetti A, Marzullo P, Sambuceti G, Di Quirico S, Kusch A, Landi P, Salvadori PA, Pisani P, L'abbate A.
    J Nucl Cardiol; 2004 Jul 15; 11(2):142-51. PubMed ID: 15052245
    [Abstract] [Full Text] [Related]

  • 12. Prediction of functional improvement of ischemic myocardium with (123I-BMIPP SPECT and 99mTc-tetrofosmin SPECT imaging: a study of patients with large acute myocardial infarction and receiving revascularization therapy.
    Seki H, Toyama T, Higuchi K, Kasama S, Ueda T, Seki R, Hatori T, Endo K, Kurabayashi M.
    Circ J; 2005 Mar 15; 69(3):311-9. PubMed ID: 15731537
    [Abstract] [Full Text] [Related]

  • 13. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P, Gallowitsch HJ.
    Acta Med Austriaca; 1996 Mar 15; 23(1-2):69-75. PubMed ID: 8767519
    [Abstract] [Full Text] [Related]

  • 14. Use of 99mTc-sestamibi SPECT/CT when conventional imaging studies are negative for localizing suspected recurrence in differentiated thyroid cancer: a method and a lesson for clinical management.
    Wu D, Ylli D, Gomes Lima CJ, Lee W, Burman KD, Wartofsky L, Van Nostrand D.
    Endocrine; 2018 Oct 15; 62(1):57-63. PubMed ID: 29797211
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 18F-FDG-PET in the follow-up of thyroid cancer.
    Lind P, Kresnik E, Kumnig G, Gallowitsch HJ, Igerc I, Matschnig S, Gomez I.
    Acta Med Austriaca; 2003 Oct 15; 30(1):17-21. PubMed ID: 12558561
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.